BETAHISTINE
SANIS HEALTH INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of BETAHISTINE in Canada?
Yes. BETAHISTINE 24MG has an active shortage reported to Health Canada (last updated December 4, 2024).
Why is BETAHISTINE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will BETAHISTINE be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
BETAHISTINE
SURAX HEALTHCARE INC
Other Products
SERC 4MG
UNIMED CANADA INC.
SERC - TAB 4MG
SOLVAY PHARMA INC
SERC 8 MG
SOLVAY PHARMA INC
SERC
BGP PHARMA ULC
AURO-BETAHISTINE
AURO PHARMA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
BETAHISTINE
BETAHISTINE: Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine.
Highest health risk
Possible match — not confirmed
TEVA-Betahistine Tablets
TEVA-Betahistine Tablets: Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine.
Highest health risk
Possible match — not confirmed
DIN
02466457
Strength
24MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from SANIS HEALTH INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02286254
400MG · DIN 02286262
100MG · DIN 02286246
400MG · DIN 02286564
70MG · DIN 02352966
10MG · DIN 02519844
12.5MG · DIN 02466821
0.50MG · DIN 02349205
0.25MG · DIN 02349191
200MG · DIN 02364336
10MG · DIN 02331292
5MG · DIN 02331284